In recent years, the assay for transposase-accessible chromatin using sequencing (ATAC-Seq) has become a fundamental tool of epigenomic research. However, it is difficult to perform this technique on frozen samples because freezing cells before extracting nuclei can impair nuclear integrity and alter chromatin structure, especially in fragile cells such as neurons. Our aim was to develop a protocol for freezing neuronal cells that is compatible with ATAC-Seq; we focused on a disease-relevant cell type, namely motor neurons differentiated from induced pluripotent stem cells (iMNs) from a patient affected by spinal muscular atrophy. We found that while flash-frozen iMNs are not suitable for ATAC-Seq, the assay is successful with slow-cooled cryopreserved cells. Using this method, we were able to isolate high quality, intact nuclei, and we verified that epigenetic results from fresh and cryopreserved iMNs quantitatively agree.
Since its establishment, the assay for transposase-accessible chromatin using sequencing (ATAC-Seq) has revolutionized the study of epigenetics1,2. This technique detects open-chromatin regions and maps transcription factor binding events genome-wide by means of direct in vitro transposition of native chromatin. Specifically, hyperactive Tn5 transposase is used to interrogate chromatin accessibility by inserting high-throughput DNA sequencing adapters into open genomic regions, which allows for the preferential amplification of DNA fragments located at sites of active chromatin. Because the DNA sites directly bound by DNA-binding proteins are protected from transposition, this approach enables the inference of transcription factor occupancy at the level of individual functional regulatory regions. Furthermore, ATAC-Seq can be utilized to decode nucleosome occupancy and positioning, by exploiting the fact that the Tn5 transposase cuts DNA with a periodicity of about 150–200 bp, corresponding to the length of the DNA fragments wrapped around histones3. This periodicity is maintained up to six nucleosomes and provides information about the spatial organization of nucleosomes within accessible chromatin. ATAC-Seq signals thus allow for the delineation of fine-scale architectures of the regulatory framework by correlating occupancy patterns with other features, such as chromatin remodeling and global gene induction programs. Compared to other epigenetic methodologies, such as FAIRE-Seq and conventional DNase-Seq, ATAC-Seq requires a small number of cells. Therefore, it is suitable for work on precious samples, including differentiated cells derived from induced pluripotent stem cells (iPSCs), primary cell culture, and limited clinical specimens. Recently developed techniques, such as single-cell DNase sequencing (scDNase-seq)4, indexing-first ChIP-Seq (iChIP)5, ultra-low-input micrococcal nuclease-based native ChIP (ULI-NChIP)6, and ChIPmentation7, allow for the epigenomic investigation of small number of cells or even single cells without requiring microfluidic devices. However, these assays require multiple experimental steps. In contrast, in ATAC-Seq the actual assay and library preparation are performed in a single enzymatic reaction. Hence, this technique is less time-consuming and labor-intensive.
It is essential to preserve the native chromatin architecture and the original nucleosome distribution patterns for ATAC-Seq. Freezing samples prior to the purification of nuclei can be detrimental to nuclear integrity and can affect chromatin structures8, thus restricting the application of ATAC-Seq to freshly-isolated nuclei. This limits the use of ATAC-Seq on clinical samples, which are typically stored frozen, and represents a major logistical hurdle for long-distance collaborative projects, for which sample freezing is often inevitable.
In an attempt to overcome this drawback, we identified a freezing protocol suitable for native chromatin-based assays on neuronal cells. We tested the freezing techniques using a disease-relevant cell type, namely motor neurons (iMNs) differentiated from human iPSCs, which were derived from the fibroblasts of a patient affected by spinal muscular atrophy (SMA). This disease is caused by homozygous loss of the SMN1 gene and is characterized by the degeneration of lower motor neurons9.
We tested two different freezing methods: flash-freezing and slow-cooling cryopreservation. Flash-freezing is a procedure in which the temperature of the sample is rapidly lowered using liquid nitrogen, dry ice or dry ice/ethanol slurry, in order to limit the formation of damaging ice crystals. Conversely, slow-cooling cryopreservation lowers the temperature of the sample gradually and makes use of cryoprotectants, such as dimethyl sulfoxide (DMSO), to prevent ice crystal nucleation and limit cell dehydration during freezing. Cryopreservation techniques are widely employed for cell banking purposes and are routinely used in assisted reproduction technologies10,11.
We introduced a number of experimental quality control (QC) checkpoints and steps for data analysis to monitor the efficacy of the procedures and quantify potential alterations induced by cell freezing.
Results and Discussion
Description of experimental design and overview of the protocol
We generated ATAC-Seq data on fresh (F), flash-frozen (FF), and cryopreserved (C) iMNs by following the procedure outlined in Fig. 1. Fresh and frozen neurons were derived from the same pool of cells and processed in parallel in order to estimate the effects of freezing on ATAC-Seq outcomes without any batch effect bias.
The ATAC-Seq protocol was adapted from Buenrostro et al.1,12, with some modifications. Given that a successful ATAC-Seq experiment begins with the isolation of high-quality intact nuclei, we first introduced a quality control checkpoint consisting of the morphological evaluation of nuclei with either Trypan Blue or DAPI staining, followed by the accurate quantification of those nuclei using an automated cell counter. Precise counting of nuclei is important to ensure optimal tagmentation (the simultaneous fragmenting of the DNA and insertion of adapter sequences) and to limit the technical variability across samples. From a qualitative perspective, individual intact nuclei with a round or oval shape should be observed with no visible clumping. To exclude samples with severe degradation or over-tagmentation, we assessed the quality of the treated chromatin samples by gel electrophoresis, as described in Buenrostro et al.12; if the chromatin was intact and the transposase reaction was optimal, a DNA laddering pattern with a periodicity of about 200 bp should be observed, corresponding to fragments of DNA that were originally protected by an integer number of nucleosomes (nucleosome phasing). Furthermore, we measured the enrichment of DNA accessible regions by performing real-time qPCR analysis using known open-chromatin sites as positive controls and Tn5-insensitive sites as a negative controls. When assayed by real-time qPCR, high-quality ATAC-Seq samples should show at least a 10-fold enrichment of positive control sites compared to Tn5-insensitive sites. Finally, as we were principally interested in open-chromatin profiling and not in nucleosome positioning, we introduced a size-selection step to enrich for nucleosome-free fragments. After size-selection, libraries were PCR-amplified and submitted for single-end sequencing.
ATAC-Seq on iPSC-derived motor neurons (iMNs): flash-frozen cells
We first performed ATAC-Seq on fresh and flash-frozen iMNs. Differentiated neuronal cells were generated as described in Methods. We performed immunocytochemistry experiments using antibodies against markers of mature motor neurons to test the efficiency of the differentiation protocol; we showed that patient-derived iPSCs were successfully differentiated into ISL1- and SMI32-positive motor neurons (Fig. 2). Figure 3 shows ATAC-Seq outcomes from two representative samples. Nuclei from fresh cells passed quality control, while nuclei from flash-frozen neurons exhibited excessive clumping, likely caused by disruption of the nuclear envelope and consequent leakage of DNA (Fig. 3A). After the transposase reaction, we assessed the quality of the resulting libraries by qualitative evaluation of agarose gel electrophoresis. The library from freshly-isolated nuclei displayed clear nucleosome phasing, while the library from flash-frozen neurons showed DNA smearing on the gel (Fig. 3B). This result strongly indicates that loss of chromatin integrity occurred during flash-freezing. We proceeded with next-generation sequencing for one fresh and one flash-frozen sample. We used the R package Gviz to plot the sequencing data along genomic coordinates for manual inspection of tracks and local visualization of peaks (Fig. 3C and Supplementary Fig. S1). As a negative control, we treated human naked DNA with the hyperactive Tn5 enzyme and sequenced this library alongside the ATAC-Seq samples. ATAC-Seq peaks from fresh neurons were sharp and overlapped with H3K4me3 signals from ENCODE ChIP-Seq datasets. Using a MACS2 q-value threshold of 0.05, we obtained more than seventy thousand significant peaks using fresh cells. In contrast, the reads from flash-frozen cells were distributed evenly across the entire genome, similar to the results obtained with the negative control, and only 461 significant peaks were detected. Half of these peaks overlapped with the peaks from fresh iMNs (see Supplementary Fig. S2).
These findings indicate that flash-freezing of iMNs is not suitable for ATAC-Seq.
ATAC-Seq on iPSC-derived motor neurons (iMNs): cryopreserved cells
Next, we compared ATAC-Seq results from fresh and cryopreserved cells. Approximately one million fresh iMNs were transferred to Cryostor media and slowly frozen, stored, and then thawed for processing (see Methods). After thawing, we assessed the cell death rate by evaluating chromatin condensation, which is a hallmark of apoptotic cells13. To this purpose, we stained the neurons with the cell-permeable Hoechst 33342, then quantified chromatin condensation using fluorescent microscopy. This dye brightly stains the condensed chromatin of cells undergoing apoptosis (see Supplementary Fig. S3). The rate of cell death was 10.8% with standard deviation of 1.7; the fraction of nuclei recovered was higher than 70% (Supplementary Table S1). As shown in Fig. 4A, nuclei from the cryopreserved cells were of high quality and the nucleosome laddering was detected by gel electrophoresis (Fig. 4B). Sequencing data from both fresh and cryopreserved samples showed sharp peaks and low background signal (Fig. 4C and Supplementary Fig. S1). Furthermore, the qPCR enrichment of the positive control site (GAPDH gene promoter, Fig. 5A top panel) over the Tn5-insensitive site (gene desert region, Fig. 5A bottom panel) was high and comparable to that of fresh cells, as opposed to qPCR results from flash-frozen neurons, for which less than 10-fold enrichment was observed (Fig. 5B). We obtained similar results using a second set of primers designed to amplify open-chromatin and gene desert regions (see Supplementary Fig. S4). As in the case of fresh cells, we obtained more than seventy thousand significant peaks using cryopreserved samples (MACS2 q-value threshold = 0.05) (Table 1). There was high overlap in the number of peaks obtained from fresh and cryopreserved iMNs (see Supplementary Fig. S5). These results reveal that slow-cooling cryopreservation of iMNs is compatible with native chromatin-based epigenetic assays.
Quantitative comparison of fresh and cryopreserved iMNs
We subsequently performed a series of analyses to quantitatively compare the results from fresh and cryopreserved neurons. We generated sequencing data on three technical replicates from both conditions to assess whether the cryopreservation method induces any modifications in chromatin accessibility. All replicates originated from the same initial batch of cells. Information about sequencing data for each sample is reported in Table 1. The percentage of reads mapping to the human genome was similar for all replicates, but cryopreserved samples displayed higher number of reads mapping to mitochondrial DNA (see Supplementary Table S2). Despite this discrepancy, we proceeded with our analysis to assess the reproducibility of the epigenetic signal from nuclear DNA across all replicates. To this purpose, we removed mtDNA reads, normalized the libraries to have the same total read counts, and examined the number of reads in 5 kb genome windows (excluding ENCODE blacklisted regions). Overall, we observed high reproducibility rates (R ≥ 0.978) between technical replicates in both fresh and cryopreserved samples (Fig. 6A). Remarkably, cryopreserved and fresh samples were almost as highly correlated to each other (R ≥ 0.973) as the technical replicates, which suggests that cryopreservation successfully preserves the read distribution across the genome. Next, we generated average read profiles at transcriptional start sites using the ngs.plot tool14. As opposed to the signal from flash-frozen iMNs, highly similar patterns were observed for fresh and cryopreserved cells (Fig. 6B). To further evaluate the similarity between cryopreserved and fresh samples, we identified the peaks in each sample and assigned each one of these peaks to neighboring features (promoters, exons, introns, distal intergenic regions and sites located downstream of the gene) within 1 kb (Fig. 6C). The distribution of peaks with respect to features in the genome was highly similar across all samples, with most of the peaks located in intergenic regions and promoters. Next, to identify and quantify potential epigenetic alterations induced by the cryopreservation procedure, we performed analysis to detect sites that were significantly different between fresh and cryopreserved samples (see Methods). MACS2-derived peaks across all samples were merged into non-overlapping unique genomic intervals resulting in 75,711 sites. We then used edgeR to detect the differences between the two conditions. We identified very few differentially enriched sites across the genome (210 out of 75,711 total = 0.28%); of these, 25.2% were located on chromosome 10, and none of them were detected on chromosome 16 (Fig. 7A). No significant regional biases were observed for the other chromosomes. The magnitude of the differences was small, never exceeding 3-fold (Fig. 7A,B). The differentially enriched sites were mainly located in intergenic regions and promoters (57.1% and 19.5%, respectively, Fig. 7C). We mapped 126 genes near these differentially enriched sites and performed Gene Ontology analysis using GOrilla15 and DAVID 6.716,17 tools. We did not detect any significant GO terms when using an adjusted p-value threshold of 0.05.
In conclusion, we established a cell freezing protocol suitable for ATAC-Seq experiments on iMNs. As in the case of fresh neurons, the cryopreserved cells passed all of the quality control checkpoints. Although we observed that higher numbers of reads map to mitochondria DNA in cryopreserved iMNs, we demonstrated that the epigenetic signal from nuclear DNA was highly reproducible between fresh and cryopreserved neurons.
We expect that the method we describe also applies to a wider variety of settings and has the potential to greatly expand the number and types of samples that can be studied with ATAC-Seq. In particular it would be interesting to test the effectiveness of this freezing procedure on additional cell types, especially heterogeneous samples such as blood-derived cells, clinical specimens and cell co-culture systems. Indeed, different cell populations might display distinct sensitivity to freezing and thawing, with consequent biases in the epigenetic outcomes. We have described a systematic approach to assess the quality of ATAC-Seq data from frozen neurons and provided guidelines that can be followed to test the applicability of this freezing method to other sample types. We anticipate that this work will be of great value to epigenetic investigators.
Ethics, Primary cells and iPSC derivation
Source fibroblast lines were obtained from Coriell Biorepository (GM09677) under their institutional review board (IRB) approved protocols. The fibroblast-derived iPSC line 77iSMA-n5 was created by the Cedars-Sinai Medical Center iPSC Core using the episomal vectors pCXLE-hUL, pCXLE-hSK, and pCXLE-hOCT3/4-shp53-F (Addgene, from a previously published protocol18) under the purview of Cedars-Sinai IRB-Stem Cell Research Oversight (SCRO) protocols, Pro00024839 and Pro00032834. The differentiation with the iPSC line was carried out under approved Cedars-Sinai IRB-SCRO protocols, Pro00036896 and Pro00021505. We transfected the fibroblasts with the vectors using the Amaxa Human Dermal Fibroblast Nucleofector Kit. The 77iSMA-n5 line was characterized by the Cedars-Sinai iPSC Core using the following quality control assays: G-Band karyotyping, immunocytochemistry for pluripotency markers, embryoid body formation, PluriTest, and qRT-PCR for endogenous pluripotency genes18,19,20,21,22.
Motor Neuron Precursors (iMPs)
The SMA patient line, 77iSMA-n5, was grown until 90% confluent using a standard iPSC maintenance protocol. On Day 0 of differentiation, iPSCs were lifted as single cells by Accutase treatment for 5 min at 37 °C. We counted the cells and re-suspended them in Neuroectoderm differentiation media (NDM + LS), which contains 1:1 IMDM/F12, 1% NEAA, 2% B-27, 1% N2, 1% Antibiotic-Antimycotic, 0.2 μM LDN193189 and 10 μM SB431542. Next, we seeded 25,000 cells/well in a 384-well plate and centrifuged the cells for 5 min at 200 rcf. On day 2, we transferred the neural aggregates to a poly 2-hydroxyethyl methacrylate (poly-Hema) coated flask and cultured them for an additional 3 days in NDM + LS media. On day 5, we seeded the neural aggregates onto a tissue culture plate coated with laminin (50 μg/mL) to induce rosette formation. From day 12–18, the attached neural aggregates were transitioned to Motor Neuron Specification Media (1:1 IMDM/F12, 1% NEAA, 2% B-27, 1% N2, 1% Antibiotic-Antimycotic, 0.25 μM all-trans retinoic acid (ATRA), 1 μM purmorphamine (PMN), 20 ng/mL brain-derived neurotrophic factor (BDNF), 20 ng/mL glial cell line-derived neurotrophic factor (GDNF), 200 ng/mL ascorbic acid (AA) and 1 μM dibutyryl cyclic-AMP (db-cAMP). On day 19 we selected the rosettes by incubating them with Neural Rosette Selection Reagent (StemCell Technologies Cat#05832) for 45 min at 37 °C. After selection, we collected the rosettes and transferred them to poly-Hema coated T75 flasks and cultured the cells as iMPs in Motor Neuron precursor expansion media (MNPEM), which contains 1:1 IMDM/F12, 1% NEAA, 2% B27, 1% N2, 1% Antibiotic-Antimycotic, 0.1 μM ATRA, 1 μM PMN, 100ng/mL EGF and 100ng/mL FGF2. We expanded the iMPs as aggregates in suspension using a mechanical passaging method known as “chopping”23,24 for up to five passages. For cryopreservation, we pooled the aggregates and dissociated them via a combined enzymatic (Accutase for 10 minutes at 37 °C) and mechanical dissociation strategy to form a single cell suspension. The single cell suspension was then concentrated via centrifugation (200 rcf for 5 minutes at 4 °C), re-suspended in Cryostor (StemCell Technologies Cat #: 07930), cryopreserved using a controlled rate freezer (Planer Inc.) and stored in gas-phase liquid nitrogen.
Motor Neuron Cultures (iMNs)
We derived the iMNs by thawing the iMPs and immediately plating the single cell suspension onto plastic tissue culture-treated plates coated with 50 μg/mL laminin for two hours at 37 °C. We seeded the iMPs in Motor Neuron Maturation Medium (MNMM) Stage 1 consisting of 1:1 IMDM/F12, 1% NEAA, 2% B-27, 1% N2, 1% Antibiotic-Antimycotic, 0.1 μM ATRA, 1 μM PMN, 10 ng/mL BDNF, 10 ng/mL GDNF, 200 ng/mL AA, 1 μM db-cAMP, and 2.5 μM N-[(3,5-Difluorophenyl)acetyl]-L-alanyl-2-phenyl]glycine-1,1-dimethylethyl ester (DAPT). We cultured the cells for a period of seven days. On day 7, the plated cultures were transitioned to MNMM Stage 2 containing 98.8% Neurobasal media, 1% non-essential amino acids, 0.5% Glutamax, 1% N2, 10 ng/mL BDNF, 10 ng/mL GDNF, 200 ng/mL AA, 1 μM db-cAMP, and 0.1 μM Ara-C. We further differentiated the iMNs in MNMM Stage 2 for a total of 21 days. On day 21, the iMNs cultures were either fixed for immunocytochemistry or collected.
Cell collection, freezing and thawing
For cell collection, the iMNs were washed once with 1X PBS, isolated via cell scraper in 1X PBS, and centrifuged at 200 rcf for 5 minutes at 4 °C. Aliquots with approximately one million cells were prepared for each experimental condition.
Flash-freezing: pellets (no supernatant) were flash-frozen in liquid nitrogen.
Cryopreservation: pellets were re-suspended in Cryostor media and frozen slowly in a Mr. Frosty isopropyl alcohol chamber (FisherSci) at −80 °C. This procedure allowed us to achieve a rate of cooling of −1 °C/minute.
Both the flash-frozen isolated cell pellets and the cryopreserved iMNs were stored for 10 days at −80 °C. To thaw the cryopreserved iMNs, we removed the cryovials from −80 °C and quickly warmed them for 2 min in a 37 °C water bath. We transferred the samples to 12 ml of warm 1X PBS supplemented with 1X protease inhibitor cocktail. We gently mixed each tube by inversion and removed an aliquot (100 μl) for cell death estimation using the chromatin condensation assay described below. We centrifuged the cells at 200 rcf for 5 min at 4 °C, carefully aspirated all the supernatant and proceeded with nuclei isolation. Flash-frozen cell pellets were removed from −80 °C and immediately re-suspended in ice-cold cell lysis buffer.
Chromatin condensation assay
Hoechst 33342 was added to 100 μl of cell suspension at a final concentration of 1.5 μg/ml. Cells were incubated for 15 min at 37 °C before proceeding with image acquisition which was carried out using a 350 nm UV excitation filter. 8 randomly selected fields per sample were imaged at 40X magnification. Neurons were scored as apoptotic when they showed condensed chromatin or fragmented nuclei with bright Hoechst signal.
We fixed iMNs with 4% paraformaldehyde and blocked them with 5% donkey serum with 0.1% Triton X-100 in 1X PBS. We incubated the cells overnight at 4 °C with the following primary antibodies: anti-SMI32 (mouse monoclonal, 1:1000, BioLegend, cat. no. SMI-32R) and anti-ISL1 (goat polyclonal, 1:250, R&D Systems, cat. no. AF1837). We subsequently rinsed the cells and incubated them with species-specific Alexa Fluor 488-conjugated secondary antibody (donkey anti-mouse immunoglobulin G (IgG), 1:1000, Life Technologies, cat. no. A-21202) and Alexa Fluor 594-conjugated secondary antibody (donkey anti-goat IgG, 1:1000, Life Technologies, cat. no. A-11058). We counterstained nuclei using DAPI (1 μg/mL). We acquired the images using Nikon/Leica microscopes with 10x magnification.
Purification of nuclei from iMNs
We re-suspended the cell pellets in ice-cold cell lysis buffer (10 mM Tris-HCl, pH 7.4, 10 mM NaCl, 3 mM MgCl2, 0.1% IGEPAL CA-630) supplemented with 1X protease inhibitor cocktail (Roche). We incubated the cells on ice for 5 min and centrifuged at 230 rcf for 5 min at 4 °C. We carefully removed the supernatant and re-suspended the nuclei in 25 μl of ice-cold 1X Tagment DNA Buffer (Illumina). We quantified the nuclei with Trypan Blue staining and the Countess® Automated Cell Counter (Invitrogen).
We purified the DNA from iMNs using the DNeasy Blood & Tissue Kit (Qiagen), according to the manufacturer’s instructions. We quantified the DNA using a NanoDrop 2000 instrument (Thermo Scientific) and used 50 ng to prepare the DNA library using the Nextera DNA Library Preparation Kit (Illumina), according to the manufacturer’s instructions. This library, obtained from naked DNA, was used as internal control to determine the background level of intrinsic accessibility of genomic DNA and correct for any Tn5 transposase sequence cleavage bias.
Chromatin tagmentation and sequencing
We used 50,000 nuclei for the transposase reaction, which was carried out as described in Buenrostro et al.1. We subsequently purified the samples with the DNA Clean & Concentrator–5 Kit (Zymo Research) and eluted them with 20 μl of Elution Buffer (Qiagen). We PCR-amplified the samples using 25 μl of Nextera PCR Master Mix (Illumina), 5 μl of PCR Primer Cocktail (Illumina), 5 μl of Index primer 1 (i7, Illumina), and 5 μl of Index primer 2 (i5, Illumina). We used the following PCR reaction protocol: 3 min 72 °C; 30 sec 98 °C; 8 cycles (10 sec 98 °C, 30 sections 63 °C, 3 min 72 °C). We purified the samples with the DNA Clean & Concentrator–5 Kit (Zymo Research), eluted them with 20 μl of Elution Buffer (Qiagen), and loaded them on 2% agarose gel (Invitrogen) for qualitative evaluation of libraries and size-selection. We size-selected the following fractions: 175–250 bp (fraction “A”, corresponding to a nucleosome-free fragment size) and 250–625 bp (fraction “B”). We purified the DNA from both gel fractions, using the QIAquick Gel Extraction Kit (Qiagen) following the manufacturer’s recommendation, and eluted it with 20 μl of Elution Buffer (Qiagen). We utilized the DNA from fraction “B” for qPCR-based qualitative analysis of libraries using primers mapping to open-chromatin regions as positive control sites and gene desert regions as negative control sites (Fig. 5 and Supplementary Fig. S4). The sequences of the primers used to amplify open-chromatin and gene desert regions are shown in Supplementary Table S3. We also performed the qPCR assay using 10-fold serial dilutions of non-transposed genomic DNA as a template to generate a calibration line for each primer pair and correct for any differences in the primer efficiency. The fold enrichment of the open-chromatin site (OC) over the Tn5-insensitive site (INS) was calculated with the following formula, as previously described25: 2 to the power of [(OCn-OCa) - (INSn-INSa)], where OCn is the qPCR threshold cycle number obtained for the OC qPCR primer pair using transposed naked DNA as template, and INSa is the qPCR threshold cycle number obtained for the INS qPCR primer pair using ATAC-Seq library as template. As an additional control, we carried out the qPCR assay using transposed naked DNA. No fold-enrichment of open-chromatin sites should be detected when using transposed naked DNA as a template. We prepared the amplification reaction with 1X KAPA SYBR FAST qPCR Master Mix (Kapa Biosystems) and 500 nM of forward and reverse primers. We carried out qPCR assays using a LightCycler® 480 Instrument II (Roche), available at the MIT BioMicroCenter. We further amplified the DNA from fraction “A” with 1X NEBNext High-Fidelity PCR Master Mix (New England Biolabs), 200 nM of Primer 1 (5′-AATGATACGGCGACCACCGA-3′), and 200 nM of Primer 2 (5′-CAAGCAGAAGACGGCATACGA-3′). We used the following PCR reaction protocol: 30 sec 98 °C; 4 cycles (10 sec 98 °C, 30 sec 65 °C, 30 sec 72 °C); 5 min 72 °C. We purified the final libraries using Agencourt AMPure XP beads (Beckman Coulter), checked their quality using a Fragment Analyzer™ instrument (Advanced Analytical), and measured their concentration by a qPCR-based method (KAPA Library Quantification Kit for Illumina Sequencing Platforms). We submitted the samples to the MIT BioMicroCenter for single-end sequencing with the Illumina HiSeq 2000 platform.
We aligned sequencing reads to the hg19 genome build using BWA v.0.7.10. We assessed the quality of the sequences using FastQC (more details on how the data was processed can be found at http://openwetware.org/wiki/BioMicroCenter:Software#BMC-BCC_Pipeline). Given the large percentage of mitochondrial reads found in some samples, we removed mitochondrial reads from the analysis using custom UNIX scripts. We determined open-chromatin regions (peaks) using MACS226 v.220.127.116.1150420 (q-value threshold = 0.05). We used the sequencing data from transposed naked DNA as a control. The differential analysis was performed using the default settings in the package DiffBind27 version 1.16.0. Briefly, read counts for each site were computed and differentially enriched sites between fresh and cryopreserved conditions were identified using the edgeR package28, with FDR <0.1.
How to cite this article: Milani, P. et al. Cell freezing protocol suitable for ATAC-Seq on motor neurons derived from human induced pluripotent stem cells. Sci. Rep. 6, 25474; doi: 10.1038/srep25474 (2016).
This work was supported by the National Institute of Health (U54-NS-091046 and U01-CA-184898), and used computing resources funded by the National Science Foundation (DB1-0821391) and sequencing support from the National Institutes of Health (P30-ES002109) through the MIT BioMicro Center. The authors are particularly grateful to Dr. Andrea Allais for his assistance with the figures and valuable comments on the manuscript.